Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Flexcell
AddedFeb 13, 2024
UpdatedJun 18, 2026
Flexcell

Flexcell

Seed

Flexcell, a US-based manufacturer, specializes in creating cell culture devices for tension, compression, and fluid shear applications.

HQ
Hillsborough, NC, US
Founded
1987
Overview
Compare
Fundraising
Employees
Website

Founded in Hillsborough, North Carolina, Flexcell specializes in manufacturing advanced cell culture devices designed to apply tension, compression, and fluid shear to cells in both 2D and 3D cultures. The company's core mission is to innovate and provide high-quality tools that facilitate groundbreaking research in cellular biomechanics. Their product lineup includes tension, compression, and tissue train systems, syringe pumps, flow and microscopy devices, as well as culture plates and slides.

Flexcell has made significant strides in the field of cell culture technology, earning recognition for its contributions to cellular research. Notable affiliated individuals include leading scientists and researchers who utilize Flexcell's devices in their work. The company has attracted investment from key stakeholders in the biotech industry, further solidifying its impact. Flexcell's products are widely used in academic and commercial laboratories, advancing our understanding of cellular responses to mechanical stimuli.

Flexcell - Similar Companies

Cell Microsystems logo

Cell Microsystems

SciKon Innovation logo

SciKon Innovation

Wilson Wolf logo

Wilson Wolf

wilsonwolf.com

3D Biotek logo

3D Biotek

3dbiotek.com

Cellutions Biosystems logo

Cellutions Biosystems

Cellibre logo

Cellibre

cellibre.com

Celularity logo

Celularity

celularity.com

Flex Biomedical logo

Flex Biomedical

flexbio.com

Cellara logo

Cellara

Flaskworks logo

Flaskworks

OpenCell Technologies logo

OpenCell Technologies

Celldom logo

Celldom

celldom.com

LaCell logo

LaCell

Fluidigm logo

Fluidigm

standardbio.com

ExpressCells logo

ExpressCells

Flexcell - Quick Facts

Who are Flexcell's competitors?

Companies similar to Flexcell include Cell Microsystems, SciKon Innovation, Wilson Wolf and 3D Biotek.

When was Flexcell founded?

Flexcell was founded in 1987.

Where is Flexcell's headquarters located?

Flexcell's headquarters is located in Hillsborough, NC, US.

When was Flexcell's last funding round?

Flexcell's most recent funding round was for $500M (USD) in June 2014.

How much has Flexcell raised to-date?

As of Jun 20, 2014, Flexcell has raised a total of $500M (USD).

How many employees does Flexcell have?

Flexcell has 30 employees as of Feb 4, 2024.

Flexcell - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Cell Culture Devices
Tags
  • Hardware
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 6 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified